Discover 65 paid clinical trials in Savannah, Georgia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Sponsor:
Merck Sharp & Dohme LLC
Location:
Code:
NCT06721156
Conditions
Alzheimer Disease
Dementia
Eligibility Criteria
Sex: All
Age: 55 - 70+
Healthy Volunteers: Not accepted
Interventions
MK-1167
Placebo
Sponsor:
Pfizer
Location:
Code:
NCT06760637
Conditions
Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
PF-07220060
letrozole
abemaciclib
palbociclib
ribociclib
Sponsor:
DualityBio Inc.
Location:
Code:
NCT06018337
Conditions
Metastatic Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
DB-1303/BNT323
Capecitabine
Paclitaxel
Nab-paclitaxel
Sponsor:
Boston Scientific Corporation
Location:
Code:
NCT06431815
Conditions
Paroxysmal Atrial Fibrillation
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
FARAPULSE™ Pulsed Field Ablation System
Sponsor:
Gilead Sciences
Location:
Code:
NCT06630299
Conditions
HIV-1-Infection
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
ISL/LEN
Antiretroviral Combinations
Sponsor:
Novo Nordisk A/S
Location:
Code:
NCT05135559
Conditions
Haemophilia A and B With and Without Inhibitors
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
Concizumab
Sponsor:
Cybin IRL Limited
Location:
Code:
NCT06564818
Conditions
Major Depressive Disorder
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
CYB003
Psychological Support
Placebo
Sponsor:
Intra-Cellular Therapies, Inc.
Location:
Code:
NCT06372964
Conditions
Bipolar Depression
Eligibility Criteria
Sex: All
Age: 10 - 17
Healthy Volunteers: Not accepted
Interventions
Lumateperone
Placebo
Sponsor:
Emory University
Location:
Code:
NCT05999084
Conditions
Alzheimer Disease
Eligibility Criteria
Sex: All
Age: 50 - 70+
Healthy Volunteers: Not accepted
Interventions
Anti-amyloid Monoclonal Antibodies (mAbs)
Standard of Care